BACKGROUND: implantation of mesh at the time of stoma formation may reduce the rate of parastomal hernia. until recently, the evidence has been limited to only a few small randomized controlled trials.
reduced the incidence of clinically detected parastomal hernia (10.8% vs 32.4%; p = 0.001) (risk ratio, 0.34; 95% Ci, 0.18-0.65; I 2 = 39%) and the rate of radiologically detected parastomal hernia (34.6% vs 55.3%; p = 0.01) (risk ratio, 0.61; 95% Ci, 0.42-0.89; I 2 = 44%). no increase in the incidence of stoma-related complications was observed with the use of prophylactic mesh. Results from ongoing and unpublished randomized controlled trials are expected, but few will report on alternative mesh types or surgical techniques. this was originally described by Bayer et al 3 in 1986 and has developed with the use of various meshes and techniques for implantation. although attempts to reinforce the stomal defect are logical, concerns exist regarding the efficacy, safety, and cost-effectiveness of mesh implantation. 4, 5 a previous, small meta-analysis of 3 randomized controlled trials (RCts) suggested a favorable effect of mesh prophylaxis, but small participant populations, heterogeneous study selection, and a high risk of bias across all cohorts limited the results. 6 new evidence from recently published RCts has emerged and justifies an updated review. this may help to clarify the evidence for mesh prophylaxis, facilitating better clinical decision making and more informed patient choice.
the primary aim of this review was to determine the effect of prophylactic mesh during primary stoma formation on the incidence of parastomal hernia. secondary aims included assessments of stoma-specific complications. in addition, we examined ongoing and unpublished studies to identify gaps in the evidence base, understand current research priorities, and guide future research efforts.
METHODS AND MATERIALS
Study Design and Outcomes a study protocol was developed in accordance to the Preferred Reporting Items for Systematic Review and Metaanalysis Protocols (PRisma-P) guidelines. 7 the study was registered prospectively on the PRosPeRo database of systematic reviews (CRD42016033679) and results reported according to PRisma guidelines. 8 Searches a systematic search strategy was designed to identify studies assessing the effect of prophylactic mesh during Gi stoma formation to prevent parastomal hernia (supplement 1, http://links.lww.com/DCR/a241). the search was initially performed on november 15, 2015 , and updated on march 25, 2016 in light of newly published evidence. two investigators independently performed systematic searches of meDline (via ovidsP), emBase (via ovidsP), and the Cochrane Database of systematic Reviews. study titles were screened for relevance before full inspection of abstracts and full texts. Discrepancies were addressed by reexamination and discussion, with involvement of a third investigator if necessary. Reference lists from relevant systematic reviews were inspected for eligible studies. all "primary registries" endorsed by the World health organization international Clinical trial Registry Platform were inspected for relevant ongoing and completed, but not yet published, trials using a modified search strategy. this included 16 international trial databases that comply with requirements set out by the international Committee of medical Journal editors (supplement 2, http://links.lww. com/DCR/a242).
9
Inclusion Criteria all RCts including adult patients (18 years and older) undergoing primary lower Gi stoma formation via open or laparoscopic approaches were eligible for inclusion. studies assessing outcomes following formation of colostomy or ileostomy (including loop or end stomas) were included. trials had to include at least 1 arm assessing the impact of mesh prophylaxis for prevention of parastomal hernia with at least 12 months follow-up, measured by either clinical or radiological examination. articles published online or in print up to march 2016 were included. other study types, including retrospective and prospective observational studies, technical notes, letters, and study protocols were excluded. Gray literature, such as conference proceedings, was excluded because of the high likelihood of incomplete data.
Outcomes the primary outcome was the rate of parastomal hernia. identification of parastomal hernia through clinical and radiological examination was handled and analyzed separately. other planned secondary outcomes were the rate of stomal complications, including hematoma, seroma, stoma-related infection, stomal stricture, stomal prolapse, and reoperation.
Definitions for this study, stoma formation was defined as creation of an artificial opening to the external environment on any section of the lower Gi tract. ostomies associated with the urogenital tract were excluded. according to definitions set out by the national institutes of health, ongoing RCts were defined as those "Recruiting" or "active but not yet recruiting."
10 "Completed" RCts were considered ongoing if less than 2 years since the recorded date of completion to allow for active clinical follow. according to the same definitions, unpublished RCts were defined as those "terminated," "Withdrawn," or "Completed" with more than 2 years since completion. several surgical techniques for placement of mesh are recognized: "onlay" implantation refers to mesh placed on the external oblique fascia if performed by an open technique, or to the peritoneum if performed by a laparoscopic technique; "sublay" refers to mesh placed in the retromuscular layer of the abdominal wall; and "inlay" refers to mesh placed under the peritoneum. techniques were determined as described in the primary trials. and loop stoma vs end stoma), mesh type (synthetic vs biological), mesh position (onlay vs inlay vs sublay), operative approach (open vs laparoscopic), primary outcome measure (clinical vs radiological), Bmi, and time of follow up. other descriptive data extracted included study population size, country of origin, and year of publication. Corresponding authors were contacted to seek missing data relevant to primary and secondary end points.
Study Quality and Bias assessment of quality and risk of bias was performed by 2 independent investigators with discrepancies addressed by discussion. the Cochrane Risk of Bias tool was used to assess the RCts included.
11 the tool assesses multiple domains of bias, including selection, detection, attrition, reporting, and other biases. all domains were assigned an overall status of "high" or "low" risk of bias, with "unclear" elements regarded as a source of "high" risk.
Statistical
Analysis the number of patients in each group was the primary unit of analysis and was used to construct risk ratios (RRs) or odds ratios (oRs) for relevant outcomes. Quantitative meta-analysis of pooled-effect estimates were calculated and presented by using forest plots. Results of each study and overall pooled effects are presented as ratios of risk or odds, alongside 95% Cis. the level of statistical significance was defined as p < 0.05 a priori. Where an adequate number of events existed across trials (greater than 10 between experimental groups), a mantel-haenszel random-effects model was used to construct risk ratios and account for the anticipated heterogeneity contained in the included studies. Where there were fewer than 10 events across both experimental groups, the Peto model was used to estimate oRs, which is more robust at extremes of power. interstudy heterogeneity was measured by using the I 2 statistic. substantial statistical heterogeneity between studies was defined as I 2 greater than 50% or a statistically significant χ 2 value (p < 0.10). in the case where statistical heterogeneity did occur, a qualitative synthesis of findings was planned through careful examination of bias and variation. all statistical analyses were performed by using Review manager 5.3 (nordic Cochrane Centre, Copenhagen).
Sensitivity Analyses sensitivity analyses on the primary outcome (parastomal hernia) were preplanned for the following groups as long as 2 or more respective RCts existed: RCts assessing the impact of biological mesh (as opposed to synthetic mesh), RCts with low risk of bias (as opposed to high risk), and RCts assessing the presence of hernia following colostomy formation (as opposed to ileostomy or mixed populations).
RESULTS

Characteristics of Included
Articles from a total of 3005 articles identified, 12 RCts met provisional inclusion criteria. two were excluded because they reported less than 12 months follow-up, 1 was excluded because of insufficient report quality, and 2 were excluded because they described multiple follow-up periods of the same population ( fig. 1 ). seven articles underwent final assessment of the primary outcome, including 464 randomly assigned participants (432 undergoing analysis) across a range of multicenter and single-center settings.
12-18 full characteristics of these trials are shown in table 1.
Total search: n=3005
Duplicates removed (n=690) Non-English manuscripts removed (n=373)
Excluded following review (n=1200)
Excluded following review (n=730)
• Nonrandomized study (n=49)
Less than 12 months of follow-up (n=2) Insufficient report quality (n=1) Duplicated report (n=2)
Review of titles: n=1942
Review of abstracts & full texts: n=742
Provisional eligibility n=12
Final eligibility n=7 Procedures and Mesh most procedures involved formation of an end-colostomy, apart from 1 trial that included a mixed population undergoing end-colostomy or end-ileostomy. there were no procedures involving loop stomas in any of the included studies. six of the 7 eligible trials used synthetic mesh, with 1 trial using porcine-derived biological mesh. mesh was placed in the sublay position (retromuscular) in 4 of 7 trials, with the remaining trials using an intraperitoneal onlay position. full characteristics including fixation methods and surgical approach are shown in table 2.
Assessment of Quality and Bias
all included studies were deemed to be at high risk of bias. all 7 trials provided adequate details of allocation concealment, and all but one described methods of random sequence allocation. one trial blinded both patients and assessors, 3 trials blinded assessors or surgeons, with no patient blinding, and 2 trials were not blinded at all. Blinding in the remaining trial was not clearly reported. other biases included 1 trial with significant loss to follow-up, and 1 trial terminated early because of strong early evidence supporting the use of prophylactic mesh ( fig. 2 ).
Assessment of Outcomes
Parastomal hernia was assessed by clinical examination in 5 trials, of which 3 also included assessment by Ct as a secondary outcome. the remaining 2 trials assessed the presence of parastomal hernia by Ct as the primary outcome. six trials (85.7%) provided definitions for parastomal hernia, but these definitions varied considerably (table 3) .
Efficacy Outcomes of 464 randomly assigned participants, 432 were available for analysis according to the intention-to-treat principle. Reasons for participant attrition across studies included failed eligibility during or after surgery (n = 21); withdrawal of consent before surgery (n = 3); loss to follow-up (n = 5); and death before 12 months of follow-up (n = 3). the incidence of clinical parastomal hernia was reduced by . 3 ). the number needed to treat to prevent 1 parastomal hernia was 5 (95% Ci, 3.3-7.2).
Safety Outcomes
there were no significant differences in rates of stomal prolapse (0.6% vs 2.9%; p = 0.09), stomal stricture (4.5% vs 1.8%; p = 0.15), or stoma-site infection (2.0% vs 1.5%; p = 0.71) between mesh and no mesh. mesh was associated with fewer reoperations within the follow-up period (2.3% vs 8.4%; p = 0.005). full data from pooled analyses of all included studies are shown in table 4. Data for hematoma or seroma formation were not available for analysis.
Sensitivity Analyses exclusion of a single RCt with mixed stomas demonstrated a further reduction in the risk of clinical parastomal hernia after formation of end-colostomy (RR, 0.27; 95% Ci, 0.16-0.48; p < 0.001; I 2 = 0%) ( fig. 4) . 15 the excluded study included both end-colostomy and end-ileostomy procedures, but limitations of the data meant it was not possible to comment on outcomes relating to end-ileostomy specifically. Preplanned sensitivity analyses for RCts assessing biological mesh and RCts with low risk of bias were not possible because of insufficient data.
Ongoing and Unpublished Trials inspection of 16 international trial registers identified 38
unique studies. all 7 studies included in the current metaanalysis were excluded. a further 18 studies were excluded due to nonmesh interventions (n = 7), non-Gi stoma formation (n = 6), and nonrandomized study design (n = 5), leaving 13 that were eligible. eleven studies were ongoing or within 2 years following completion, with a total anticipated population of 1603 participants (table 5) . the majority of these tested synthetic mesh, with a sublay position being the most common position of implantation. the surgical approaches used in these studies (laparoscopic vs open) were commonly not disclosed, but the limited data available suggested a broad mix of approaches in ongoing studies. almost all these studies (n = 10/11; 90.1%) aimed to follow up patients at least 12 months after the primary procedure (range, 6-120 months). Quality-of-life assess- "A hernia associated with stoma appliance dysfunction and leakage not responsive to conservative measures, parastomal skin breakdown related to sheer injury or ischemia from pressure on the thinned parastomal skin, and recurrent partial bowel obstruction" Lambrecht et al 16 "A bulge associated with the stoma" ments were planned in 6 of 11 (54.5%) and assessments of cost-effectiveness were planned in 3 of 11 (27.3%). the remaining trials (2/11; 18.2%) were unpublished at ≥2 years after completion, with a total anticipated population of 340 participants.
DISCUSSION
the results of this study show that placement of mesh at the time of stoma formation significantly reduces the incidence of parastomal hernia. this is evident when assessed by using either clinical or radiological outcome measures. in addition, placement of mesh appears safe and does not increase the incidence of postoperative adverse events. these results must be balanced with inherent limitations of the primary evidence, including heterogeneous interventions and a high risk of bias seen across all included studies.
there are several approaches for parastomal hernia repair, including local tissue repair, stoma relocation, and mesh reinforcement. all are associated with considerable rates of hernia recurrence (46%-100% vs 0%-72.2% vs 0%-33%), which has driven interest in mesh prophylaxis. 1 Risks of complications associated with this approach include stoma-site infection and stricture, which have contributed to a cautious uptake among surgeons. however, evidence from recent RCts suggests good efficacy and safety for mesh prophylaxis in small study populations and may represent a superior approach. the current meta-analysis demonstrates a reduction of parastomal hernia with prophylactic mesh, with no significant increases in stoma-related complications. the rate of stoma-site infections was similar between mesh and nonmesh groups, and, whereas a small increase in stricture rate was identified (4.5% vs 1.8%), the difference was not statistically significant. the smaller incidence of parastomal hernia with mesh was detected by using both clinical and radiological outcome measures. it is noteworthy that the overall rate of detection was far greater when assessed using Ct, which likely is explained because of the detection of clinically asymptomatic hernias. the number needed to treat to prevent 1 parastomal hernia was 5 according to both clinical and radiological outcomes, suggesting a good treatment effect. included in this study was an evaluation of ongoing and unpublished trials, which was performed to better understand current research priorities and to make recommendations for future research. a number of trials were identified from online registers, with a combined population exceeding 1600 patients. one of these, the PReVent study (ntR2018; trialsregister.nl), is expected to publish outcomes in the next 12 months, with interim outcomes already reported. 20, 21 the strengths of this study compared with the current literature include a larger study population and patient blinding, but the absence of assessor blinding may be a limitation. Publication of other trials is expected in the next 12 to 24 months, with most expected to report outcomes relating only to synthetic mesh materials. this leaves a number of questions unanswered, including the efficacy and safety of alternative mesh types and positions of implantation. Biological and composite meshes have gained interest recently as concerns of comorbidity associated with synthetic polypropylene mesh have grown. 4 in addition, it has been suggested that meshrelated comorbidity such as contamination may be reduced by intraperitoneal placement of mesh, but others have raised concerns over the risk of intestinal obstruction related to this approach. 4, 22 evidence from high-quality RCts to investigate these issues is lacking, and future studies should broaden their scope to assess the safety and efficacy of multiple materials and techniques. future studies may also wish to extend their portfolio of outcomes, including patient-reported measures and evaluations of cost-effectiveness. finally, identified within this assessment was a small number of completed trials with no published evidence after at least 2 years following primary completion. these represent hidden trial data and implicate wasted resources through unrealized data. 23 investigators should aim for timely and complete dissemination of results to inform best current practice.
a previous meta-analysis of prophylactic mesh by shabbir et al 6 reported outcomes from 3 RCts. small patient populations, heterogeneous interventions, and a high risk of bias in the primary studies limited the conclusions drawn from this analysis. notably, one study included patients undergoing temporary loop stomas, with most subjects undergoing reversal at a median time of 5 to 7 months after formation. 24 there are suggestions that hernias associated with loop stomas develop within 3 months , but this timescale is likely insufficient to ensure reliable and complete detection of all hernias.
1,25 the current updated meta-analysis excluded this study, according to a minimum follow-up period of 12 months, and included 5 additional RCts published during or after 2012. one of these included a mixed population of patients undergoing end-colostomy and end-ileostomy, which was included to maximize available evidence, while been subjected to an appropriate subanalysis. 15 another study tested biological meshes, whereas all others used synthetic materials. this is notable, because the biological mesh series contributed approximately 25% of the overall pooled population, and, unlike other studies, failed to demonstrate improved outcomes with mesh. further investigation into the safety and efficacy of biological mesh, and its performance compared with synthetic materials, is indicated. finally, despite previous calls for a large, robust RCt, a high risk of bias persisted in all studies in the current review. 6 a major source of bias arose from inadequate blinding, with most studies failing to blind both subjects and assessors. this was augmented by events such as early trial termination in 1 study because of strong interim evidence supporting prophylactic mesh, which may have introduced bias through falsely inflated effect sizes. 26 this topic remains a priority research area, acknowledged by both the american society of Colon and Rectal surgeons and the association of Coloproctology of Great Britain & ireland. 27, 28 strengths of the current study include an outline of ongoing studies. this is important because, although the volume of evidence for prophylactic mesh has increased, the respective gaps in evidence still persist in ongoing research. the results should raise awareness of these issues and guide future trial designs and priorities. limitations of this meta-analysis are recognized and should be considered when interpreting the results. first, a heterogeneous mixture of synthetic and biological meshes placed in different anatomical planes is inherently problematic for meta-analysis. this is particularly notable in the absence of sufficient data to perform reliable subanalyses for clinically important variables. second, disparity in the clinical definition of parastomal hernia and variable follow-up periods across all studies added further heterogeneity to the studies' outcome measures. We attempted to address this inherent heterogeneity by selecting models based on their performance for meta-analysis; however, residual error is likely to remain. the data presented by this meta-analysis appear to support the safety and efficacy of prophylactic mesh to prevent parastomal hernia. however, inherent limitations of the primary evidence hinder reliable, unbiased assessment, and ongoing trials still lack assessment of alternative mesh types and techniques. this study represents best current evidence, but there is a continued need for larger, higher-quality RCts with broader scopes of assessment. this may be achieved by more complex, multiarm clinical trial designs.
